Condition
Advanced Cholangiocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Advanced Cholangiocarcinoma clinical trials that are recruiting, at sites in 13 countries (most in China (3), United States (3), Argentina (1)). By phase: Phase 2 (3), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 13Countries
Newest Advanced Cholangiocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pemigatinib plus atezolizumab and bevacizumab for advanced FGFR2‑fusion cholangiocarcinoma | Phase 1/2 | Houston, Texas | Recruiting | Jun 3, 2024 |
| At-home cancer treatment versus clinic-based treatment for advanced cancer patients | Phase 2 | Jacksonville, Florida and 1 other locations | Recruiting | Aug 1, 2023 |
| Combination treatment for advanced cholangiocarcinoma | Phase 3 | Hangzhou, Zhejiang | Recruiting | Apr 21, 2023 |
| Futibatinib treatment for advanced cholangiocarcinoma with FGFR2 gene changes | Phase 2 | La Jolla, California and 64 other locations | Recruiting | Feb 14, 2023 |
| Combining Lenvatinib, Tislelizumab, Gemcitabine, and Cisplatin for Advanced Cholangiocarcinoma | Phase 2 | Hangzhou, Zhejiang | Recruiting | Sep 8, 2022 |
All recruiting trials (5)
-
Pemigatinib plus atezolizumab and bevacizumab for advanced FGFR2‑fusion cholangiocarcinoma
This trial tests whether adding pemigatinib to atezolizumab and bevacizumab can help control advanced cholangiocarcinoma in patients whose tumors have an FGFR2 fusion.
-
At-home cancer treatment versus clinic-based treatment for advanced cancer patients
This study tests whether giving cancer treatment at home is better for comfort and satisfaction compared to getting it at a clinic for people with advanced cancer.
-
Combination treatment for advanced cholangiocarcinoma
This study is testing a new combination of four drugs to see if it can help people with advanced cholangiocarcinoma feel better and improve their treatment results.
-
Futibatinib treatment for advanced cholangiocarcinoma with FGFR2 gene changes
This study is testing if two different doses of a new drug called futibatinib can help people with advanced bile duct cancer that has specific gene changes feel better after other treatments.
-
Combining Lenvatinib, Tislelizumab, Gemcitabine, and Cisplatin for Advanced Cholangiocarcinoma
This study is testing a new combination of four cancer drugs to see if it can help people with advanced bile duct cancer feel better and have more treatment options.
Related topics
Quick answers
How many Advanced Cholangiocarcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in China (3 trials), United States (3 trials), Argentina (1 trial), Australia (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.